1. Home
  2. SWAG vs JSPR Comparison

SWAG vs JSPR Comparison

Compare SWAG & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stran & Company Inc.

SWAG

Stran & Company Inc.

HOLD

Current Price

$1.37

Market Cap

29.1M

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

SELL

Current Price

$0.56

Market Cap

26.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SWAG
JSPR
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
26.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SWAG
JSPR
Price
$1.37
$0.56
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
18.6K
★ 358.3K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.82
19.22
EPS
★ 0.06
N/A
Revenue
★ $116,191,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.17
★ N/A
Revenue Growth
★ 40.58
N/A
52 Week Low
$1.32
$0.32
52 Week High
$3.50
$2.69

Technical Indicators

Market Signals
Indicator
SWAG
JSPR
Relative Strength Index (RSI) 35.50 39.85
Support Level $1.32 $0.42
Resistance Level $1.84 $0.60
Average True Range (ATR) 0.08 0.05
MACD 0.00 -0.00
Stochastic Oscillator 16.92 4.88

Price Performance

Historical Comparison
SWAG
JSPR

About SWAG Stran & Company Inc.

Stran & Co Inc is an outsourced marketing solutions provider, working closely with customers to develop sophisticated marketing programs that leverage promotional products and loyalty incentive expertise. In addition to selling branded products, it offers its clients custom sourcing capabilities, which is a flexible and customizable e-commerce solution for promoting branded merchandise and other promotional products, managing promotional loyalty and incentives, print collateral, event assets, order and inventory management, and designing and hosting online retail pop-up shops. The company's segment consists of the Stran segment and the SLS segment. The company generates the majority of its revenue from the Stran segment.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: